Oct 2026
Design and Rationale of the CLASP II TR Randomized Trial for Severe Tricuspid Regurgitation.
The CLASP II TR trial will inform the safety and effectiveness of the PASCAL system compared to medical therapy alone in the treatment of patients with symptomatic, severe tricuspid regurgitation.
G. Ailawadi, Charles J. Davidson, Allen S. Anderson et al.
· American Heart Journal · 0 citations